SWAV - ShockWave Medical, Inc.
| Previous Close | 56.21 |
| Open | 56.20 |
| Bid | 55.66 x 1000 |
| Ask | 55.70 x 900 |
| Day's Range | 54.90 - 56.50 |
| 52 Week Range | 24.58 - 66.76 |
| Volume | 265,611 |
| Avg. Volume | 497,833 |
| Market Cap | 1.577B |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -12.07 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41.75 |
- Motley Fool•2 days ago
The 3 Best-Performing IPOs of 2019 (So Far)
Yes, there's still a chance to catch the buzz of these three very popular new stocks.
- GlobeNewswire•8 days ago
Shockwave Appoints Keith D. Dawkins M.D. as Chief Medical Officer
Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that the Company has appointed Keith D. Dawkins, M.D. as Chief Medical Officer. “Given the challenges associated with treating calcium throughout the cardiovascular system, joining Shockwave and contributing to the development of what will likely become the new standard of care for calcium modification was an attractive opportunity,” said Dr. Dawkins.
- Motley Fool•13 days ago
Here's Why ShockWave Medical Jumped for a Second Straight Day
The medical device maker is on fire.
- Motley Fool•13 days ago
ShockWave Medical's Revenue Soars in Its Public Debut
The medical device maker's first earnings report as a public company featured explosive revenue growth and upbeat full-year guidance.
- American City Business Journals•13 days ago
The Funded: Mixed results from Bay Area's non-Uber IPOs this week
A South San Francisco biotech's offering soared on Thursday, but a San Mateo ruggedized smartphone maker's priced well below its targets. Here's more on that and other Bay Area founder and funder news at the end of the week.
- Motley Fool•14 days ago
Here's Why ShockWave Medical Jumped Higher Today
The medical-device maker is off to a good start as a public company.
Motley Fool•15 days agoShockWave Medical, Inc. (SWAV) Q1 2019 Earnings Call Transcript
SWAV earnings call for the period ending March 31, 2019.
- Associated Press•15 days ago
Shockwave Medical: 1Q Earnings Snapshot
The Fremont, California-based company said it had a loss of $1.37 per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- GlobeNewswire•15 days ago
Shockwave Medical Reports First Quarter 2019 Financial Results
SANTA CLARA, Calif., May 08, 2019 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
Motley Fool•15 days ago4 IPOs That Have More Than Doubled in 2019
ShockWave Medical, Zoom Video, Jumia, and PagerDuty have all soared since going public in March or April of this year.
Motley Fool•15 days agoWhy ShockWave Medical Stock Soared 30% in April
The medical device maker's stock has been on a tear since its March IPO.
- American City Business Journals•20 days ago
New TechVenture Index showed a big drop in first quarter
The measure of the health of the venture and startup world has dropped for two straight quarters now, down from 17-year highs by about 15 percent.
- Motley Fool•21 days ago
Abiomed Comes Up Short as Growth Slows
The medical device maker failed to reach its financial targets in the final quarter of its fiscal year.
- GlobeNewswire•22 days ago
Shockwave Medical to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
SANTA CLARA, Calif., May 01, 2019 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
- American City Business Journals•23 days ago
San Mateo-based ruggedized smart phone maker sets IPO targets
The company joins joins what could be a busy month for Bay Area IPOs in May, which is expected to include Uber's massive offering, Slack's direct listing and the market debut of South San Francisco biotech Cortexyme.
- Benzinga•27 days ago
3 Stocks To Watch Ahead Of Earnings
These three health and technology stocks are seeing technical strength ahead of upcoming earnings. Evolus, Inc. (NASDAQ: EOLS ) gained 50 cents to $26.44 on 537,100 shares Wednesday. The performance beauty ...
- MarketWatch•28 days ago
Harry Boxer’s three stocks to watch this week
Evolus Inc. (EOLS) gained 50 cents to $26.44 on 537,100 shares traded Wednesday. The performance-beauty company said it will release earnings after the close of the stock market April 30. Extreme Networks Inc. (EXTR) rose 29 cents to $8.26 on 2.1 million shares traded Wednesday, nearly 1 1/2 times its average volume.
- GlobeNewswire•29 days ago
Shockwave Medical to Report First Quarter 2019 Financial Results on May 8, 2019
SANTA CLARA, Calif., April 24, 2019 -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat.
- American City Business Journals•last month
These 10 VC-backed companies scored the biggest Bay Area exits in Q1
The number of Bay Area exits via IPOs and M&A; in the first quarter dropped sharply to 40, according to PitchBook Data, less than half the total from last year's first quarter.
- American City Business Journals•2 months ago
Silk Road Medical soars 81% after raising $120M in upsized IPO
The Sunnyvale-based medical device business sold 6 million shares at $20 each instead of the 4.7 million shares it originally planned to sell for between $15 and $17 apiece.
- GlobeNewswire•2 months ago
Shockwave Completes Enrollment of Disrupt CAD II Study
Shockwave Medical, Inc. (SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, has completed enrollment of its DISRUPT CAD II study, a regulatory-required European post-market registry of coronary IVL. DISRUPT CAD II is a prospective, non-randomized, multicenter, real-world study to confirm the safety and performance results from the DISRUPT CAD I study, which was used to obtain European approval of the Shockwave Coronary IVL System.
- GuruFocus.com•2 months ago
5 IPOs Doing Better Than Lyft in 2019
Each company to debut this year has gained, except the ride-hailing startup
- GlobeNewswire•2 months ago
ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ShockWave Medical, Inc. (“ShockWave”) (SWAV), today announced the closing of its initial public offering of 6,555,000 shares of its common stock at an initial public offering price of $17.00 per share, including 855,000 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares. ShockWave’s common stock is listed on the Nasdaq Global Select Market under the ticker symbol “SWAV”. Morgan Stanley and BofA Merrill Lynch acted as joint lead book-running managers for the offering.
- American City Business Journals•2 months ago
Why Shockwave Medical jumped nearly 86% in its first two days on Wall Street
"I feel like a kid in a candy store right now," CEO Doug Godshall told the Business Journal after his company's first day of trading on Wall Street. Here's what's next for Shockwave after its blockbuster debut on the Nasdaq.
- American City Business Journals•2 months ago
The Funded: 6 fundings, 6 M&A deals at week's end in Bay Area
Six fundings, six acquisition deals and another company getting set to go public highlight Bay Area venture news at the end of the week. Here's more of those and other founder and funder news from the region.
